Basic Information
Basic information for ALG1L9P-201-63aa
Peptide Name ALG1L9P-201-63aa
Genome Position chr11:71813575-71813763[-]
Species Human
Peptide Sequence MGPEHPRRCPPRAPQRLRWRGGRARLREKQRQRGLEDPGYGALGRLAWVGLSPFGGTPGFWCR
Peptide Length 63
Unique No (ALG1L9P-202-63aa,ALG1L9P-208-63aa,ALG1L9P-209-63aa)
Grand Average of Hydropathicity -1.0492
Relative Molecular Mass 8326.24
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000248671;ALG1L9P
Transcript ID/Name ENST00000508969;ALG1L9P-201
Transcript Length 2165
Coding Ability 0.3409
DNA Sequence Corresponding to Peptide ATGGGCCCGGAGCATCCTCGGCGCTGCCCTCCCAGAGCCCCGCAGAGGCTGAGGTGGCGCGGGGGGCGGGCCCGGCTCCGCGAGAAGCAGCGGCAGCGAGGGCTGGAGGACCCGGGCTACGGGGCTCTGGGGCGTCTGGCCTGGGTGGGACTGAGCCCATTCGGGGGGACTCCGGGGTTCTGGTGTAGG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :